Afreen, S

Defining the role of Id2 in human erythropoiesis

Agraz-Doblas, A

Chromosome segregation defects as early underlying pathogenic mechanism in hyperdiploid childhood B-cell acute lymphoblastic leukaemia

Alawi, M

Comparative integrative analysis of primary and relapsed atypical teratoid/rhabdoid tumors (AT/RTs)

Alejo, O

Cooperativity between miR-125b and Gata1 s in the pathogenesis of Down syndrome-associated myeloid leukemia

Alonso, C

The interplay between IKZF1 and COBL deletions in leukemia

Alsadeq, A

Chemokine receptor expression in central nervous system (CNS) positive childhood acute lymphoblastic leukemia

CD79a impacts central nervous system (CNS) infiltration of pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL)

Anderson, J

SMARCB1-Dependencies in Malignant Rhabdoid Tumours: A strategy for Pre-Clinical Therapeutic Target Identification in the Absence of Actionable Mutations

Intra- and extra-cranial Malignant Rhabdoid Tumours share common location-independent clinical and molecular disease characteristics.

Anguita, E

Adoptive Cellular Immunotherapy using CD1a CART-cells for Treatment of Cortical Pediatric T-Cell Acute Lymphoblastic Leukemia

Antonelli, M

Comparative integrative analysis of primary and relapsed atypical teratoid/rhabdoid tumors (AT/RTs)

Avery, A

Intra- and extra-cranial Malignant Rhabdoid Tumours share common location-independent clinical and molecular disease characteristics.

Bailey, S

SMARCB1-Dependencies in Malignant Rhabdoid Tumours: A strategy for Pre-Clinical Therapeutic Target Identification in the Absence of Actionable Mutations

Intra- and extra-cranial Malignant Rhabdoid Tumours share common location-independent clinical and molecular disease characteristics.

Ballerini, P

Chromosome segregation defects as early underlying pathogenic mechanism in hyperdiploid childhood B-cell acute lymphoblastic leukaemia

Barker, JM

SMARCB1-Dependencies in Malignant Rhabdoid Tumours: A strategy for Pre-Clinical Therapeutic Target Identification in the Absence of Actionable Mutations

Baroni, ML

Adoptive Cellular Immunotherapy using CD1a CART-cells for Treatment of Cortical Pediatric T-Cell Acute Lymphoblastic Leukemia

Batting, S

SMARCB1-Dependencies in Malignant Rhabdoid Tumours: A strategy for Pre-Clinical Therapeutic Target Identification in the Absence of Actionable Mutations

Bäuerle, T

Cell free circulating tumor DNA represents a serum marker in Ewing sarcoma patients – update of the EFACT study

Beck, A

The role of BCORL1 in hepatoblastoma

Beckett, M

In vitro and in vivo genome wide CRISPR screening under drug treatment in T-ALL

Berner, R

Morphorheological changes of neutrophils in patients with neutropenic fever

Bhayadia, R

Patient-derived xenografts for pre-clinical drug development in AML

Blair, H

Therapeutic targeting of the leukaemic fusion gene RUNX1/ETO

In vitro and in vivo genome wide CRISPR screening under drug treatment in T-ALL

Identification of glycolytic pathway as RUNX1/ETO-dependent for propagation and survival

Blair, HJ

The oncogenic transcription factor RUNX1/ETO corrupts the cell cycle to drive leukaemic transformation

Bleckmann, K

Methotrexate-associated toxicity during therapy of acute lymphoblastic leukemia in children with Down syndrome

Bock, M

Response and Resistance of ALK-mutated Neuroblastoma Cells to Ceritinib

Response and Resistance of ALK-mutated Neuroblastoma Cells to Ceritinib

Bohler, S

Defining the role of Id2 in human erythropoiesis

Bonifer, C

The oncogenic transcription factor RUNX1/ETO corrupts the cell cycle to drive leukaemic transformation

Bosch-Boras, E

Exosomal (exo) dsDNA as a diagnostic and prognostic tool in pediatric solid tumours

Brennan, B

SMARCB1-Dependencies in Malignant Rhabdoid Tumours: A strategy for Pre-Clinical Therapeutic Target Identification in the Absence of Actionable Mutations

Intra- and extra-cranial Malignant Rhabdoid Tumours share common location-independent clinical and molecular disease characteristics.

Bueno, C

Chromosome segregation defects as early underlying pathogenic mechanism in hyperdiploid childhood B-cell acute lymphoblastic leukaemia

Adoptive Cellular Immunotherapy using CD1a CART-cells for Treatment of Cortical Pediatric T-Cell Acute Lymphoblastic Leukemia

Calasanz, MJ

Chromosome segregation defects as early underlying pathogenic mechanism in hyperdiploid childhood B-cell acute lymphoblastic leukaemia

Camos, M

Chromosome segregation defects as early underlying pathogenic mechanism in hyperdiploid childhood B-cell acute lymphoblastic leukaemia

Campbell, PJ

Modelling the progression of a preleukemic stage to overt leukemia in children with Down syndrome

Campos, M

Adoptive Cellular Immunotherapy using CD1a CART-cells for Treatment of Cortical Pediatric T-Cell Acute Lymphoblastic Leukemia

Cantilena, S

Redeployed drug inducing MLL fusion degradation

Cario, G

Targeting CD38 in T-ALL using a novel Fc-engineered antibody

Chemokine receptor expression in central nervous system (CNS) positive childhood acute lymphoblastic leukemia

CD79a impacts central nervous system (CNS) infiltration of pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL)

Methotrexate-associated toxicity during therapy of acute lymphoblastic leukemia in children with Down syndrome

Carlet, M

CD79a impacts central nervous system (CNS) infiltration of pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL)

Castella, M

Adoptive Cellular Immunotherapy using CD1a CART-cells for Treatment of Cortical Pediatric T-Cell Acute Lymphoblastic Leukemia

Clifford, SC

SMARCB1-Dependencies in Malignant Rhabdoid Tumours: A strategy for Pre-Clinical Therapeutic Target Identification in the Absence of Actionable Mutations

Intra- and extra-cranial Malignant Rhabdoid Tumours share common location-independent clinical and molecular disease characteristics.

Crispino, JD

Modelling the progression of a preleukemic stage to overt leukemia in children with Down syndrome

Crosier, S

SMARCB1-Dependencies in Malignant Rhabdoid Tumours: A strategy for Pre-Clinical Therapeutic Target Identification in the Absence of Actionable Mutations

Intra- and extra-cranial Malignant Rhabdoid Tumours share common location-independent clinical and molecular disease characteristics.

Dal Porto, A

Therapeutic targeting of the leukaemic fusion gene RUNX1/ETO

Danßmann, C

Circular RNAs in Neuroblastoma

de Boer, J

Redeployed drug inducing MLL fusion degradation

del-Carpio Pons, A

SMARCB1-Dependencies in Malignant Rhabdoid Tumours: A strategy for Pre-Clinical Therapeutic Target Identification in the Absence of Actionable Mutations

Dirksen, U

Cell free circulating tumor DNA represents a serum marker in Ewing sarcoma patients – update of the EFACT study

Duployez, N

The interplay between IKZF1 and COBL deletions in leukemia

Ebersberger, I

DCAL goes NGS: Unveiling the complexity of MLL rearrangements using targeted-DNA sequencing

Eckert, C

Monitoring of minimal residual disease in MYCN-amplified neuroblastoma by chromosomal breakpoint recognition

Human-zebrafish xenograft platform to individualise therapy for acute lymphoblastic leukaemia patients (ALL-ZeFiX)

Eggert, A

Response and Resistance of ALK-mutated Neuroblastoma Cells to Ceritinib

Monitoring of minimal residual disease in MYCN-amplified neuroblastoma by chromosomal breakpoint recognition

Response and Resistance of ALK-mutated Neuroblastoma Cells to Ceritinib

Hippo-YAP pathway activation favors neuroblastoma progression

Preclinical evaluation of BET-inhibition as monotherapy and combination therapy in MYC-driven neuroblastoma

Circular RNAs in Neuroblastoma

Eichholz, KM

Targeting CD38 in T-ALL using a novel Fc-engineered antibody

Emerenciano, M

The interplay between IKZF1 and COBL deletions in leukemia

DCAL goes NGS: Unveiling the complexity of MLL rearrangements using targeted-DNA sequencing

Emmrich, S

Cooperativity between miR-125b and Gata1 s in the pathogenesis of Down syndrome-associated myeloid leukemia

CRISPRi screening to identify functional long noncoding RNAs in pediatric acute myeloid leukemia

Erlacher, M

Defining the role of Id2 in human erythropoiesis

Fairchild, AR

Intra- and extra-cranial Malignant Rhabdoid Tumours share common location-independent clinical and molecular disease characteristics.

Finetti, MA

SMARCB1-Dependencies in Malignant Rhabdoid Tumours: A strategy for Pre-Clinical Therapeutic Target Identification in the Absence of Actionable Mutations

Intra- and extra-cranial Malignant Rhabdoid Tumours share common location-independent clinical and molecular disease characteristics.

Firle, KA

Preclinical evaluation of BET-inhibition as monotherapy and combination therapy in MYC-driven neuroblastoma

Fischer, M

Monitoring of minimal residual disease in MYCN-amplified neuroblastoma by chromosomal breakpoint recognition

Frühwald, MC

Comparative integrative analysis of primary and relapsed atypical teratoid/rhabdoid tumors (AT/RTs)

Fuchs, J

The non functional-P2X7-receptor in pediatric solid tumors

Methadone potentiates the cytostatic effect in Rhabdomyosarcoma and malignant Rhabdoid Tumors

Fuchs, S

Response and Resistance of ALK-mutated Neuroblastoma Cells to Ceritinib

Response and Resistance of ALK-mutated Neuroblastoma Cells to Ceritinib

Circular RNAs in Neuroblastoma

Fuster, JL

Adoptive Cellular Immunotherapy using CD1a CART-cells for Treatment of Cortical Pediatric T-Cell Acute Lymphoblastic Leukemia

Gauert, A

Human-zebrafish xenograft platform to individualise therapy for acute lymphoblastic leukaemia patients (ALL-ZeFiX)

Gesche, J

The non functional-P2X7-receptor in pediatric solid tumors

Gialesaki, S

Functional and molecular characterization of oncogenic dependencies on chromosome 21 in Down syndrome-associated myeloid leukemia

Giebel, B

Evaluation of dsDNA from extracellular vesicles (EVs) as biomarker in pediatric AML

Biomarker potential of mRNA in extracellular vesicles in pediatric AML

Comparison of differential ultracentrifugation (DC) and size exclusion chromatography (SEC) based exosome isolation methods

Gillmann, C

Cell free circulating tumor DNA represents a serum marker in Ewing sarcoma patients – update of the EFACT study

Grabovska, Y

SMARCB1-Dependencies in Malignant Rhabdoid Tumours: A strategy for Pre-Clinical Therapeutic Target Identification in the Absence of Actionable Mutations

Intra- and extra-cranial Malignant Rhabdoid Tumours share common location-independent clinical and molecular disease characteristics.

Gramatzki, M

Targeting CD38 in T-ALL using a novel Fc-engineered antibody

Granada, I

Chromosome segregation defects as early underlying pathogenic mechanism in hyperdiploid childhood B-cell acute lymphoblastic leukaemia

Guck, J

Morphorheological changes of neutrophils in patients with neutropenic fever

Gupta, S

The interplay between IKZF1 and COBL deletions in leukemia

Habeler, C

Comparative integrative analysis of primary and relapsed atypical teratoid/rhabdoid tumors (AT/RTs)

Hacking, J

SMARCB1-Dependencies in Malignant Rhabdoid Tumours: A strategy for Pre-Clinical Therapeutic Target Identification in the Absence of Actionable Mutations

Handgretinger, R

Methadone potentiates the cytostatic effect in Rhabdomyosarcoma and malignant Rhabdoid Tumors

Hargrave, D

SMARCB1-Dependencies in Malignant Rhabdoid Tumours: A strategy for Pre-Clinical Therapeutic Target Identification in the Absence of Actionable Mutations

Intra- and extra-cranial Malignant Rhabdoid Tumours share common location-independent clinical and molecular disease characteristics.

Hasselblatt, M

Comparative integrative analysis of primary and relapsed atypical teratoid/rhabdoid tumors (AT/RTs)

Heckl, D

Functional and molecular characterization of oncogenic dependencies on chromosome 21 in Down syndrome-associated myeloid leukemia

Cooperativity between miR-125b and Gata1 s in the pathogenesis of Down syndrome-associated myeloid leukemia

Patient-derived xenografts for pre-clinical drug development in AML

Deciphering the genetically interactive network of the DLK1-DIO3 ncRNA locus in the hematopoietic system and pediatric acute megakaryoblastic leukemia

Modelling the progression of a preleukemic stage to overt leukemia in children with Down syndrome

CRISPRi screening to identify functional long noncoding RNAs in pediatric acute myeloid leukemia

Deciphering the oncogenic network of PRC-2 loss guided leukemogenesis

Heeren-Hagemann, A

Human-zebrafish xenograft platform to individualise therapy for acute lymphoblastic leukaemia patients (ALL-ZeFiX)

Heidenreich, O

The oncogenic transcription factor RUNX1/ETO corrupts the cell cycle to drive leukaemic transformation

Therapeutic targeting of the leukaemic fusion gene RUNX1/ETO

Investigating novel drug combinations against patient-derived xenografts of acute lymphoblastic leukaemia

Redeployed drug inducing MLL fusion degradation

Identification of glycolytic pathway as RUNX1/ETO-dependent for propagation and survival

Hein, AS

The non functional-P2X7-receptor in pediatric solid tumors

Hertwig, F

Response and Resistance of ALK-mutated Neuroblastoma Cells to Ceritinib

Monitoring of minimal residual disease in MYCN-amplified neuroblastoma by chromosomal breakpoint recognition

Response and Resistance of ALK-mutated Neuroblastoma Cells to Ceritinib

Hippo-YAP pathway activation favors neuroblastoma progression

Preclinical evaluation of BET-inhibition as monotherapy and combination therapy in MYC-driven neuroblastoma

Circular RNAs in Neuroblastoma

Heukamp, L

Monitoring of minimal residual disease in MYCN-amplified neuroblastoma by chromosomal breakpoint recognition

Heukmann, J

Monitoring of minimal residual disease in MYCN-amplified neuroblastoma by chromosomal breakpoint recognition

Heuser, M

Therapeutic targeting of the leukaemic fusion gene RUNX1/ETO

Heydebrand, F von

Differences in stroma cell signaling after contact to acute lymphoblastic leukemia B-cells derived from adult and pediatric patients

Hobeika, E

CD79a impacts central nervous system (CNS) infiltration of pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL)

Holdhof, D

Loss of SMARCA4 in neural progenitor cells causes rosette-forming proliferative lesions in the developing mouse brain

Holsten, T

Comparative integrative analysis of primary and relapsed atypical teratoid/rhabdoid tumors (AT/RTs)

Hundsdoerfer, P

Monitoring of minimal residual disease in MYCN-amplified neuroblastoma by chromosomal breakpoint recognition

Hundsdörfer, P

Response and Resistance of ALK-mutated Neuroblastoma Cells to Ceritinib

Response and Resistance of ALK-mutated Neuroblastoma Cells to Ceritinib

Irving, J

Investigating novel drug combinations against patient-derived xenografts of acute lymphoblastic leukaemia

Isa, A

The oncogenic transcription factor RUNX1/ETO corrupts the cell cycle to drive leukaemic transformation

Identification of glycolytic pathway as RUNX1/ETO-dependent for propagation and survival

Islam, A

Chromosome segregation defects as early underlying pathogenic mechanism in hyperdiploid childhood B-cell acute lymphoblastic leukaemia

Issa, H

The oncogenic transcription factor RUNX1/ETO corrupts the cell cycle to drive leukaemic transformation

Therapeutic targeting of the leukaemic fusion gene RUNX1/ETO

Identification of glycolytic pathway as RUNX1/ETO-dependent for propagation and survival

Jacques, TS

SMARCB1-Dependencies in Malignant Rhabdoid Tumours: A strategy for Pre-Clinical Therapeutic Target Identification in the Absence of Actionable Mutations

Intra- and extra-cranial Malignant Rhabdoid Tumours share common location-independent clinical and molecular disease characteristics.

Jeremias, I

CD79a impacts central nervous system (CNS) infiltration of pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL)

A target-specific reporter system to enrich cells with CRISPR/Cas9-induced knockout

Jumaa, H

CD79a impacts central nervous system (CNS) infiltration of pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL)

Jyotsana, N

Therapeutic targeting of the leukaemic fusion gene RUNX1/ETO

Kadel, S

Functional and molecular characterization of oncogenic dependencies on chromosome 21 in Down syndrome-associated myeloid leukemia

Kappler, R

The role of BCORL1 in hepatoblastoma

SP8 promotes an aggressive phenotype of hepatoblastoma cells

Kellner, C

Targeting CD38 in T-ALL using a novel Fc-engineered antibody

Klironomos, F

Response and Resistance of ALK-mutated Neuroblastoma Cells to Ceritinib

Response and Resistance of ALK-mutated Neuroblastoma Cells to Ceritinib

Circular RNAs in Neuroblastoma

Klusmann, JH

Functional and molecular characterization of oncogenic dependencies on chromosome 21 in Down syndrome-associated myeloid leukemia

Cooperativity between miR-125b and Gata1 s in the pathogenesis of Down syndrome-associated myeloid leukemia

Patient-derived xenografts for pre-clinical drug development in AML

Deciphering the genetically interactive network of the DLK1-DIO3 ncRNA locus in the hematopoietic system and pediatric acute megakaryoblastic leukemia

Modelling the progression of a preleukemic stage to overt leukemia in children with Down syndrome

CRISPRi screening to identify functional long noncoding RNAs in pediatric acute myeloid leukemia

Deciphering the oncogenic network of PRC-2 loss guided leukemogenesis

Klussman, JH

Redeployed drug inducing MLL fusion degradation

Knoess, S

Functional and molecular characterization of oncogenic dependencies on chromosome 21 in Down syndrome-associated myeloid leukemia

Knöß, S

Deciphering the oncogenic network of PRC-2 loss guided leukemogenesis

Koch, A

Comparative integrative analysis of primary and relapsed atypical teratoid/rhabdoid tumors (AT/RTs)

Komkov, A

High-throughput sequencing of clonal TCR alpha genes rearrangements in pediatric T-lineage acute lymphoblastic leukemia

Comparison of NGS and RT-PCR approaches for MRD monitoring in acute lymphoblastic leukemia

Kontopoulou, E

Evaluation of dsDNA from extracellular vesicles (EVs) as biomarker in pediatric AML

Biomarker potential of mRNA in extracellular vesicles in pediatric AML

Exosomal (exo) dsDNA as a diagnostic and prognostic tool in pediatric solid tumours

Comparison of differential ultracentrifugation (DC) and size exclusion chromatography (SEC) based exosome isolation methods

Kool, M

Comparative integrative analysis of primary and relapsed atypical teratoid/rhabdoid tumors (AT/RTs)

Krause, T

The role of BCORL1 in hepatoblastoma

Krippner-Heidenreich, A

In vitro and in vivo genome wide CRISPR screening under drug treatment in T-ALL

Kroll, M

Methotrexate-associated toxicity during therapy of acute lymphoblastic leukemia in children with Down syndrome

Krumbholz, M

Differences in stroma cell signaling after contact to acute lymphoblastic leukemia B-cells derived from adult and pediatric patients

Cell free circulating tumor DNA represents a serum marker in Ewing sarcoma patients – update of the EFACT study

Kunz, F

Biomarker potential of mRNA in extracellular vesicles in pediatric AML

Labuhn, M

Cooperativity between miR-125b and Gata1 s in the pathogenesis of Down syndrome-associated myeloid leukemia

Modelling the progression of a preleukemic stage to overt leukemia in children with Down syndrome

Larghero, P

DCAL goes NGS: Unveiling the complexity of MLL rearrangements using targeted-DNA sequencing

Law, E

Investigating novel drug combinations against patient-derived xenografts of acute lymphoblastic leukaemia

Lebedev, Y

High-throughput sequencing of clonal TCR alpha genes rearrangements in pediatric T-lineage acute lymphoblastic leukemia

Lenk, L

Targeting CD38 in T-ALL using a novel Fc-engineered antibody

Chemokine receptor expression in central nervous system (CNS) positive childhood acute lymphoblastic leukemia

CD79a impacts central nervous system (CNS) infiltration of pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL)

Liu, WH

A target-specific reporter system to enrich cells with CRISPR/Cas9-induced knockout

Lopes, BA

The interplay between IKZF1 and COBL deletions in leukemia

DCAL goes NGS: Unveiling the complexity of MLL rearrangements using targeted-DNA sequencing

Lowis, S

SMARCB1-Dependencies in Malignant Rhabdoid Tumours: A strategy for Pre-Clinical Therapeutic Target Identification in the Absence of Actionable Mutations

Intra- and extra-cranial Malignant Rhabdoid Tumours share common location-independent clinical and molecular disease characteristics.

Luli, S

Identification of glycolytic pathway as RUNX1/ETO-dependent for propagation and survival

Lunec, J

Investigating novel drug combinations against patient-derived xenografts of acute lymphoblastic leukaemia

Lutzny-Geier, G

Differences in stroma cell signaling after contact to acute lymphoblastic leukemia B-cells derived from adult and pediatric patients

Mackensen, A

Differences in stroma cell signaling after contact to acute lymphoblastic leukemia B-cells derived from adult and pediatric patients

Mamedov, I

High-throughput sequencing of clonal TCR alpha genes rearrangements in pediatric T-lineage acute lymphoblastic leukemia

Comparison of NGS and RT-PCR approaches for MRD monitoring in acute lymphoblastic leukemia

Marschalek, R

The interplay between IKZF1 and COBL deletions in leukemia

DCAL goes NGS: Unveiling the complexity of MLL rearrangements using targeted-DNA sequencing

Marteens, JHA

Redeployed drug inducing MLL fusion degradation

Martinez-Soria, N

The oncogenic transcription factor RUNX1/ETO corrupts the cell cycle to drive leukaemic transformation

Identification of glycolytic pathway as RUNX1/ETO-dependent for propagation and survival

Maschan, M

High-throughput sequencing of clonal TCR alpha genes rearrangements in pediatric T-lineage acute lymphoblastic leukemia

McKenzie, L

The oncogenic transcription factor RUNX1/ETO corrupts the cell cycle to drive leukaemic transformation

Investigating novel drug combinations against patient-derived xenografts of acute lymphoblastic leukaemia

Identification of glycolytic pathway as RUNX1/ETO-dependent for propagation and survival

Menendez, P

Chromosome segregation defects as early underlying pathogenic mechanism in hyperdiploid childhood B-cell acute lymphoblastic leukaemia

Adoptive Cellular Immunotherapy using CD1a CART-cells for Treatment of Cortical Pediatric T-Cell Acute Lymphoblastic Leukemia

Menon, R

Monitoring of minimal residual disease in MYCN-amplified neuroblastoma by chromosomal breakpoint recognition

Metzler, M

Differences in stroma cell signaling after contact to acute lymphoblastic leukemia B-cells derived from adult and pediatric patients

Cell free circulating tumor DNA represents a serum marker in Ewing sarcoma patients – update of the EFACT study

Meyer, C

The interplay between IKZF1 and COBL deletions in leukemia

DCAL goes NGS: Unveiling the complexity of MLL rearrangements using targeted-DNA sequencing

Miroshnichenkova, A

High-throughput sequencing of clonal TCR alpha genes rearrangements in pediatric T-lineage acute lymphoblastic leukemia

Comparison of NGS and RT-PCR approaches for MRD monitoring in acute lymphoblastic leukemia

Molina, O

Chromosome segregation defects as early underlying pathogenic mechanism in hyperdiploid childhood B-cell acute lymphoblastic leukaemia

Möricke, A

Methotrexate-associated toxicity during therapy of acute lymphoblastic leukemia in children with Down syndrome

Müller, A

Defining the role of Id2 in human erythropoiesis

Nakjang, S

Identification of glycolytic pathway as RUNX1/ETO-dependent for propagation and survival

Neuhoff, N von

Evaluation of dsDNA from extracellular vesicles (EVs) as biomarker in pediatric AML

Neuhoff von, N

Biomarker potential of mRNA in extracellular vesicles in pediatric AML

Ng, M

CRISPRi screening to identify functional long noncoding RNAs in pediatric acute myeloid leukemia

Niesen, J

PIK3CA mutations significantly enhance the growth of Shh medulloblastoma

Nugmanov, G

High-throughput sequencing of clonal TCR alpha genes rearrangements in pediatric T-lineage acute lymphoblastic leukemia

O'Hare, P

SMARCB1-Dependencies in Malignant Rhabdoid Tumours: A strategy for Pre-Clinical Therapeutic Target Identification in the Absence of Actionable Mutations

Intra- and extra-cranial Malignant Rhabdoid Tumours share common location-independent clinical and molecular disease characteristics.

Oh, SH

DCAL goes NGS: Unveiling the complexity of MLL rearrangements using targeted-DNA sequencing

Ohli, J

PIK3CA mutations significantly enhance the growth of Shh medulloblastoma

Olk, N

Human-zebrafish xenograft platform to individualise therapy for acute lymphoblastic leukaemia patients (ALL-ZeFiX)

Olshanskaya, Y

High-throughput sequencing of clonal TCR alpha genes rearrangements in pediatric T-lineage acute lymphoblastic leukemia

Comparison of NGS and RT-PCR approaches for MRD monitoring in acute lymphoblastic leukemia

Oostendorp, RAJ

Differences in stroma cell signaling after contact to acute lymphoblastic leukemia B-cells derived from adult and pediatric patients

Overath, MD

Monitoring of minimal residual disease in MYCN-amplified neuroblastoma by chromosomal breakpoint recognition

Pal, D

Chromosome segregation defects as early underlying pathogenic mechanism in hyperdiploid childhood B-cell acute lymphoblastic leukaemia

Palmi, C

The interplay between IKZF1 and COBL deletions in leukemia

Papaemmanuil, E

Modelling the progression of a preleukemic stage to overt leukemia in children with Down syndrome

Peipp, M

Targeting CD38 in T-ALL using a novel Fc-engineered antibody

Perez-Iribarne, MM

Chromosome segregation defects as early underlying pathogenic mechanism in hyperdiploid childhood B-cell acute lymphoblastic leukaemia

Perkins, K

Modelling the progression of a preleukemic stage to overt leukemia in children with Down syndrome

Pflumio, F

Adoptive Cellular Immunotherapy using CD1a CART-cells for Treatment of Cortical Pediatric T-Cell Acute Lymphoblastic Leukemia

Pickles, JC

Intra- and extra-cranial Malignant Rhabdoid Tumours share common location-independent clinical and molecular disease characteristics.

Pizer, B

SMARCB1-Dependencies in Malignant Rhabdoid Tumours: A strategy for Pre-Clinical Therapeutic Target Identification in the Absence of Actionable Mutations

Intra- and extra-cranial Malignant Rhabdoid Tumours share common location-independent clinical and molecular disease characteristics.

Plensa, I

Chromosome segregation defects as early underlying pathogenic mechanism in hyperdiploid childhood B-cell acute lymphoblastic leukaemia

Pogodzinski, MJ

Monitoring of minimal residual disease in MYCN-amplified neuroblastoma by chromosomal breakpoint recognition

Raible, A

Methadone potentiates the cytostatic effect in Rhabdomyosarcoma and malignant Rhabdoid Tumors

Ramli, R

SMARCB1-Dependencies in Malignant Rhabdoid Tumours: A strategy for Pre-Clinical Therapeutic Target Identification in the Absence of Actionable Mutations

Reinhardt, D

Evaluation of dsDNA from extracellular vesicles (EVs) as biomarker in pediatric AML

Biomarker potential of mRNA in extracellular vesicles in pediatric AML

Exosomal (exo) dsDNA as a diagnostic and prognostic tool in pediatric solid tumours

Comparison of differential ultracentrifugation (DC) and size exclusion chromatography (SEC) based exosome isolation methods

Ridgwell, D

SMARCB1-Dependencies in Malignant Rhabdoid Tumours: A strategy for Pre-Clinical Therapeutic Target Identification in the Absence of Actionable Mutations

Rizzi, M

Defining the role of Id2 in human erythropoiesis

Roca-Ho, H

Chromosome segregation defects as early underlying pathogenic mechanism in hyperdiploid childhood B-cell acute lymphoblastic leukaemia

Rodríguez-Perales, S

Chromosome segregation defects as early underlying pathogenic mechanism in hyperdiploid childhood B-cell acute lymphoblastic leukaemia

Sanchez-Martinez, D

Adoptive Cellular Immunotherapy using CD1a CART-cells for Treatment of Cortical Pediatric T-Cell Acute Lymphoblastic Leukemia

Schachtrup, K

Defining the role of Id2 in human erythropoiesis

Scheer, C

Modelling the progression of a preleukemic stage to overt leukemia in children with Down syndrome

Schewe, D

Methotrexate-associated toxicity during therapy of acute lymphoblastic leukemia in children with Down syndrome

Schewe, DM

Targeting CD38 in T-ALL using a novel Fc-engineered antibody

Chemokine receptor expression in central nervous system (CNS) positive childhood acute lymphoblastic leukemia

CD79a impacts central nervous system (CNS) infiltration of pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL)

Schmid, E

The non functional-P2X7-receptor in pediatric solid tumors

Methadone potentiates the cytostatic effect in Rhabdomyosarcoma and malignant Rhabdoid Tumors

Schneider, D

Deciphering the genetically interactive network of the DLK1-DIO3 ncRNA locus in the hematopoietic system and pediatric acute megakaryoblastic leukemia

Deciphering the oncogenic network of PRC-2 loss guided leukemogenesis

Schönbeck, K

Response and Resistance of ALK-mutated Neuroblastoma Cells to Ceritinib

Monitoring of minimal residual disease in MYCN-amplified neuroblastoma by chromosomal breakpoint recognition

Response and Resistance of ALK-mutated Neuroblastoma Cells to Ceritinib

Hippo-YAP pathway activation favors neuroblastoma progression

Preclinical evaluation of BET-inhibition as monotherapy and combination therapy in MYC-driven neuroblastoma

Schramm, A

Hippo-YAP pathway activation favors neuroblastoma progression

Schrappe, M

Targeting CD38 in T-ALL using a novel Fc-engineered antibody

Chemokine receptor expression in central nervous system (CNS) positive childhood acute lymphoblastic leukemia

CD79a impacts central nervous system (CNS) infiltration of pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL)

Methotrexate-associated toxicity during therapy of acute lymphoblastic leukemia in children with Down syndrome

Schüller, U

Comparative integrative analysis of primary and relapsed atypical teratoid/rhabdoid tumors (AT/RTs)

Loss of SMARCA4 in neural progenitor cells causes rosette-forming proliferative lesions in the developing mouse brain

PIK3CA mutations significantly enhance the growth of Shh medulloblastoma

Schulte, JH

Response and Resistance of ALK-mutated Neuroblastoma Cells to Ceritinib

Monitoring of minimal residual disease in MYCN-amplified neuroblastoma by chromosomal breakpoint recognition

Response and Resistance of ALK-mutated Neuroblastoma Cells to Ceritinib

Hippo-YAP pathway activation favors neuroblastoma progression

Preclinical evaluation of BET-inhibition as monotherapy and combination therapy in MYC-driven neuroblastoma

Circular RNAs in Neuroblastoma

Schwalbe, EC

Intra- and extra-cranial Malignant Rhabdoid Tumours share common location-independent clinical and molecular disease characteristics.

Schwarzer, A

CRISPRi screening to identify functional long noncoding RNAs in pediatric acute myeloid leukemia

Deciphering the oncogenic network of PRC-2 loss guided leukemogenesis

Schweinitz, D von

The role of BCORL1 in hepatoblastoma

SP8 promotes an aggressive phenotype of hepatoblastoma cells

Selby, MP

SMARCB1-Dependencies in Malignant Rhabdoid Tumours: A strategy for Pre-Clinical Therapeutic Target Identification in the Absence of Actionable Mutations

Intra- and extra-cranial Malignant Rhabdoid Tumours share common location-independent clinical and molecular disease characteristics.

Shi, Y

In vitro and in vivo genome wide CRISPR screening under drug treatment in T-ALL

Sigl, S

The role of BCORL1 in hepatoblastoma

Smith, A

SMARCB1-Dependencies in Malignant Rhabdoid Tumours: A strategy for Pre-Clinical Therapeutic Target Identification in the Absence of Actionable Mutations

Intra- and extra-cranial Malignant Rhabdoid Tumours share common location-independent clinical and molecular disease characteristics.

Spohn, M

Comparative integrative analysis of primary and relapsed atypical teratoid/rhabdoid tumors (AT/RTs)

Stagno, MJ

The non functional-P2X7-receptor in pediatric solid tumors

Methadone potentiates the cytostatic effect in Rhabdomyosarcoma and malignant Rhabdoid Tumors

Strachan, S

Exosomal (exo) dsDNA as a diagnostic and prognostic tool in pediatric solid tumours

Comparison of differential ultracentrifugation (DC) and size exclusion chromatography (SEC) based exosome isolation methods

Suttorp, M

Morphorheological changes of neutrophils in patients with neutropenic fever

Szoltysek, K

Investigating novel drug combinations against patient-derived xenografts of acute lymphoblastic leukaemia

Szymansky, A

Monitoring of minimal residual disease in MYCN-amplified neuroblastoma by chromosomal breakpoint recognition

Hippo-YAP pathway activation favors neuroblastoma progression

Preclinical evaluation of BET-inhibition as monotherapy and combination therapy in MYC-driven neuroblastoma

Taub, JW

Modelling the progression of a preleukemic stage to overt leukemia in children with Down syndrome

Thakur, B

Comparison of differential ultracentrifugation (DC) and size exclusion chromatography (SEC) based exosome isolation methods

Thakur, BK

Evaluation of dsDNA from extracellular vesicles (EVs) as biomarker in pediatric AML

Biomarker potential of mRNA in extracellular vesicles in pediatric AML

Exosomal (exo) dsDNA as a diagnostic and prognostic tool in pediatric solid tumours

Tirtakusuma, R

The oncogenic transcription factor RUNX1/ETO corrupts the cell cycle to drive leukaemic transformation

Toedling, J

Response and Resistance of ALK-mutated Neuroblastoma Cells to Ceritinib

Monitoring of minimal residual disease in MYCN-amplified neuroblastoma by chromosomal breakpoint recognition

Response and Resistance of ALK-mutated Neuroblastoma Cells to Ceritinib

Hippo-YAP pathway activation favors neuroblastoma progression

Preclinical evaluation of BET-inhibition as monotherapy and combination therapy in MYC-driven neuroblastoma

Circular RNAs in Neuroblastoma

Toepfner, N

Morphorheological changes of neutrophils in patients with neutropenic fever

Toribio, ML

Adoptive Cellular Immunotherapy using CD1a CART-cells for Treatment of Cortical Pediatric T-Cell Acute Lymphoblastic Leukemia

Tsaur, G

The interplay between IKZF1 and COBL deletions in leukemia

van Delft, F

In vitro and in vivo genome wide CRISPR screening under drug treatment in T-ALL

Verboon, L

Deciphering the genetically interactive network of the DLK1-DIO3 ncRNA locus in the hematopoietic system and pediatric acute megakaryoblastic leukemia

Vogiatzi, F

Targeting CD38 in T-ALL using a novel Fc-engineered antibody

CD79a impacts central nervous system (CNS) infiltration of pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL)

Völse, K

A target-specific reporter system to enrich cells with CRISPR/Cas9-induced knockout

Vormoor, J

Investigating novel drug combinations against patient-derived xenografts of acute lymphoblastic leukaemia

Vossen-Gajcy, M

Chemokine receptor expression in central nervous system (CNS) positive childhood acute lymphoblastic leukemia

Vyas, P

Modelling the progression of a preleukemic stage to overt leukemia in children with Down syndrome

Wagner, AE

SP8 promotes an aggressive phenotype of hepatoblastoma cells

Warmann, SW

The non functional-P2X7-receptor in pediatric solid tumors

Methadone potentiates the cytostatic effect in Rhabdomyosarcoma and malignant Rhabdoid Tumors

Weiss, MJ

Modelling the progression of a preleukemic stage to overt leukemia in children with Down syndrome

Williams, O

Redeployed drug inducing MLL fusion degradation

Williamson, D

SMARCB1-Dependencies in Malignant Rhabdoid Tumours: A strategy for Pre-Clinical Therapeutic Target Identification in the Absence of Actionable Mutations

Intra- and extra-cranial Malignant Rhabdoid Tumours share common location-independent clinical and molecular disease characteristics.

Winkler, A

Monitoring of minimal residual disease in MYCN-amplified neuroblastoma by chromosomal breakpoint recognition

Hippo-YAP pathway activation favors neuroblastoma progression

Circular RNAs in Neuroblastoma

Wirbelauer, T

Chemokine receptor expression in central nervous system (CNS) positive childhood acute lymphoblastic leukemia

Witthauer, MJ

Monitoring of minimal residual disease in MYCN-amplified neuroblastoma by chromosomal breakpoint recognition

Hippo-YAP pathway activation favors neuroblastoma progression

Preclinical evaluation of BET-inhibition as monotherapy and combination therapy in MYC-driven neuroblastoma

Wood, JA

SMARCB1-Dependencies in Malignant Rhabdoid Tumours: A strategy for Pre-Clinical Therapeutic Target Identification in the Absence of Actionable Mutations

Xu, J

Deciphering the genetically interactive network of the DLK1-DIO3 ncRNA locus in the hematopoietic system and pediatric acute megakaryoblastic leukemia

Deciphering the oncogenic network of PRC-2 loss guided leukemogenesis

Zerkalenkova, E

Comparison of NGS and RT-PCR approaches for MRD monitoring in acute lymphoblastic leukemia

zur Stadt, U

DCAL goes NGS: Unveiling the complexity of MLL rearrangements using targeted-DNA sequencing